Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -728.14%-799.97K | -2,516.63%-664.78K | -13,954.94%-302.88K | -181.29%-2.03M | -5,667.63%-1.91M | 75.99%-96.6K | 81.10%-25.41K | 98.59%-2.16K | 82.90%-722.29K | 85.22%-33.07K |
| Net income from continuing operations | -316.53%-2.27M | -69.96%-627.91K | -18.65%-370.28K | 14.19%-2.05M | -29.25%-827.63K | 20.79%-544.29K | 27.64%-369.45K | 43.75%-312.07K | 56.02%-2.39M | 12.32%-640.35K |
| Operating gains losses | ---18K | ---658 | --899 | 256.56%2.97K | ---- | ---- | ---- | ---- | -113.31%-1.9K | -286.96%-15.21K |
| Depreciation and amortization | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 0.00%37.2K | -1,037.28%-87.17K |
| Remuneration paid in stock | 1,276.81%1.14M | --0 | -74.60%3.33K | 137.25%641.94K | 3,238.52%537.47K | 86.14%82.75K | -92.62%8.6K | -85.96%13.12K | -73.52%270.58K | -88.77%16.1K |
| Other non cashItems | 235.56%119.89K | 270.73%116.29K | 266.08%112.9K | 16.27%211.79K | -26.19%113.85K | 144.75%35.73K | -68.14%31.37K | 231.62%30.84K | 9.64%182.15K | 83.56%154.25K |
| Change In working capital | -34.83%214.56K | -150.15%-152.5K | -118.70%-49.74K | -170.61%-834.97K | -421.56%-1.73M | 54.66%329.21K | 46.61%304.07K | 19.28%265.95K | 5,201.54%1.18M | 106.08%539.31K |
| -Change in receivables | -282.86%-12.54K | -3,729.17%-1.84K | 168.33%2.79K | -148.88%-1.38K | -67.56%907 | -234.79%-3.27K | 98.21%-48 | 277.82%1.04K | 218.28%2.82K | -82.91%2.8K |
| -Change in prepaid assets | ---19.13K | -45.13%15.77K | --152.33K | -484.02%-138.43K | -29,123.78%-167.18K | --0 | 28.03%28.75K | --0 | 225,193.75%36.05K | 106.57%576 |
| -Change in payables and accrued expense | -25.95%246.22K | -160.44%-166.43K | -177.33%-204.85K | -160.78%-695.17K | -392.56%-1.57M | 61.38%332.48K | 46.76%275.37K | 23.74%264.91K | 5,594.22%1.14M | 110.91%535.94K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -728.14%-799.97K | -2,516.63%-664.78K | -13,954.94%-302.88K | -181.29%-2.03M | -5,667.63%-1.91M | 75.99%-96.6K | 81.10%-25.41K | 98.59%-2.16K | 82.90%-722.29K | 85.22%-33.07K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -117.5K | 0 | ||||||||
| Net PPE purchase and sale | ---117.5K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---117.5K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 5,768.61%6.71M | 323.79%2.98M | 14,473.46%2.85M | -71.38%114.42K | -72.76%25K | 0 | -57.57%704.24K | -84.36%19.52K | ||
| Net issuance payments of debt | --0 | ---- | ---- | 2,186.17%1.97M | 9,387.06%1.85M | 175.38%94.42K | 2,119.39%25K | --0 | -93.05%86.24K | -84.36%19.52K |
| Net common stock issuance | ---- | ---- | ---- | 63.91%1.01M | --1.01M | ---- | ---- | ---- | 84.04%618K | --0 |
| Proceeds from stock option exercised by employees | --726.05K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 5,768.61%6.71M | ---- | ---- | 323.79%2.98M | 14,473.46%2.85M | -71.38%114.42K | -72.76%25K | --0 | -57.57%704.24K | -84.36%19.52K |
| Net cash flow | ||||||||||
| Beginning cash position | 1,066.17%29.75K | 22,050.36%654.99K | 18,637.68%957.87K | -79.14%5.11K | 240.87%20.37K | -69.95%2.55K | -94.23%2.96K | -79.14%5.11K | -99.06%24.51K | -95.18%5.98K |
| Current changes in cash | 32,438.69%5.8M | -153,899.26%-625.24K | -13,954.94%-302.88K | 5,378.44%952.76K | 7,018.33%937.5K | 807.83%17.82K | 99.05%-406 | -105.30%-2.16K | 99.30%-18.05K | 86.31%-13.55K |
| Effect of exchange rate changes | --12.47K | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 89.13%-1.35K | 3,395.58%12.69K |
| End cash Position | 28,570.44%5.84M | 1,066.17%29.75K | 22,050.36%654.99K | 18,637.68%957.87K | 18,637.68%957.87K | 240.87%20.37K | -69.95%2.55K | -94.23%2.96K | -79.14%5.11K | -79.14%5.11K |
| Free cash from | -849.77%-917.47K | -2,607.38%-687.84K | -13,954.94%-302.88K | -181.29%-2.03M | -5,667.63%-1.91M | 75.99%-96.6K | 81.10%-25.41K | 98.59%-2.16K | 82.90%-722.29K | 85.22%-33.07K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.